Home Aminos (2R)-2-amino-3-(prop-2-en-1-yldisulfanyl)propanoic acid

(2R)-2-amino-3-(prop-2-en-1-yldisulfanyl)propanoic acid

CAS No.:
2281-22-3
Catalog Number:
AG01ELWI
Molecular Formula:
C6H11NO2S2
Molecular Weight:
193.2870
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
Product Description
Catalog Number:
AG01ELWI
Chemical Name:
(2R)-2-amino-3-(prop-2-en-1-yldisulfanyl)propanoic acid
CAS Number:
2281-22-3
Molecular Formula:
C6H11NO2S2
Molecular Weight:
193.2870
MDL Number:
MFCD11983096
IUPAC Name:
(2R)-2-amino-3-(prop-2-enyldisulfanyl)propanoic acid
InChI:
InChI=1S/C6H11NO2S2/c1-2-3-10-11-4-5(7)6(8)9/h2,5H,1,3-4,7H2,(H,8,9)/t5-/m0/s1
InChI Key:
WYQZZUUUOXNSCS-YFKPBYRVSA-N
SMILES:
N[C@H](C(=O)O)CSSCC=C
Properties
Complexity:
141  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Defined Bond Stereocenter Count:
0
Exact Mass:
193.023g/mol
Formal Charge:
0
Heavy Atom Count:
11  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
193.279g/mol
Monoisotopic Mass:
193.023g/mol
Rotatable Bond Count:
6  
Topological Polar Surface Area:
114A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-2  
Literature
Title Journal
S-allylmercaptocysteine reduces carbon tetrachloride-induced hepatic oxidative stress and necroinflammation via nuclear factor kappa B-dependent pathways in mice. European journal of nutrition 20120401
A garlic derivative, S-allylcysteine (SAC), suppresses proliferation and metastasis of hepatocellular carcinoma. PloS one 20120101
Microtubule destabilization is shared by genetic and idiopathic Parkinson's disease patient fibroblasts. PloS one 20120101
The antioxidant mechanisms underlying the aged garlic extract- and S-allylcysteine-induced protection. Oxidative medicine and cellular longevity 20120101
S-allylmercaptocysteine effectively inhibits the proliferation of colorectal cancer cells under in vitro and in vivo conditions. Cancer letters 20111101
Nonvolatile S-alk(en)ylthio-L-cysteine derivatives in fresh onion (Allium cepa L. cultivar). Journal of agricultural and food chemistry 20110914
Potential beneficial effects of garlic in oncohematology. Mini reviews in medicinal chemistry 20110601
Predicting cyclooxygenase inhibition by three-dimensional pharmacophoric profiling. Part II: Identification of enzyme inhibitors from Prasaplai, a Thai traditional medicine. Phytomedicine : international journal of phytotherapy and phytopharmacology 20110115
Identification of a novel function of Id-1 in mediating the anticancer responses of SAMC, a water-soluble garlic derivative, in human bladder cancer cells. Molecular medicine reports 20110101
Anticancer activity of S-allylmercapto-L-cysteine on implanted tumor of human gastric cancer cell. Biological & pharmaceutical bulletin 20110101
Chemopreventive effect of PSP through targeting of prostate cancer stem cell-like population. PloS one 20110101
H2S donor, S-propargyl-cysteine, increases CSE in SGC-7901 and cancer-induced mice: evidence for a novel anti-cancer effect of endogenous H2S? PloS one 20110101
Polaprezinc Protects Mice against Endotoxin Shock. Journal of clinical biochemistry and nutrition 20100501
Cysteine and glutathione mixed-disulfide conjugates of thiosulfinates: chemical synthesis and biological activities. Journal of agricultural and food chemistry 20100210
Allicin up-regulates cellular glutathione level in vascular endothelial cells. European journal of nutrition 20090301
Structural, chemical and biological aspects of antioxidants for strategies against metal and metalloid exposure. Oxidative medicine and cellular longevity 20090101
Gamma-tocotrienol suppresses prostate cancer cell proliferation and invasion through multiple-signalling pathways. British journal of cancer 20081202
Allium compounds, dipropyl and dimethyl thiosulfinates as antiproliferative and differentiating agents of human acute myeloid leukemia cell lines. Biologics : targets & therapy 20081201
Induction of apoptosis by S-allylmercapto-L-cysteine, a biotransformed garlic derivative, on a human gastric cancer cell line. International journal of molecular medicine 20080601
Evidence of a novel docetaxel sensitizer, garlic-derived S-allylmercaptocysteine, as a treatment option for hormone refractory prostate cancer. International journal of cancer 20080501
Inhibition of cell growth and induction of apoptosis via inactivation of NF-kappaB by a sulfurcompound isolated from garlic in human colon cancer cells. Journal of pharmacological sciences 20070801
S-allylcysteine, a water-soluble garlic derivative, suppresses the growth of a human androgen-independent prostate cancer xenograft, CWR22R, under in vivo conditions. BJU international 20070401
Garlic-derived S-allylmercaptocysteine is a novel in vivo antimetastatic agent for androgen-independent prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 20070315
A novel anticancer effect of garlic derivatives: inhibition of cancer cell invasion through restoration of E-cadherin expression. Carcinogenesis 20061101
Diallyl trisulfide suppresses the proliferation and induces apoptosis of human colon cancer cells through oxidative modification of beta-tubulin. The Journal of biological chemistry 20051216
Effects of a series of organosulfur compounds on mitotic arrest and induction of apoptosis in colon cancer cells. Molecular cancer therapeutics 20050901
Garlic arrests MDA-MB-435 cancer cells in mitosis, phosphorylates the proapoptotic BH3-only protein BimEL and induces apoptosis. British journal of cancer 20050509
Allicin and allicin-derived garlic compounds increase breath acetone through allyl methyl sulfide: use in measuring allicin bioavailability. Journal of agricultural and food chemistry 20050323
Aminotransferase, L-amino acid oxidase and beta-lyase reactions involving L-cysteine S-conjugates found in allium extracts. Relevance to biological activity? Biochemical pharmacology 20050115
Suppression of the nuclear factor-kappaB activation pathway by spice-derived phytochemicals: reasoning for seasoning. Annals of the New York Academy of Sciences 20041201
S-allylmercaptocysteine scavenges hydroxyl radical and singlet oxygen in vitro and attenuates gentamicin-induced oxidative and nitrosative stress and renal damage in vivo. BMC clinical pharmacology 20040101
Garlic's ability to prevent in vitro Cu2+-induced lipoprotein oxidation in human serum is preserved in heated garlic: effect unrelated to Cu2+-chelation. Nutrition journal 20040101
Induction of apoptosis by the garlic-derived compound S-allylmercaptocysteine (SAMC) is associated with microtubule depolymerization and c-Jun NH(2)-terminal kinase 1 activation. Cancer research 20031015
Garlic [Allium sativum]: a review of its potential use as an anti-cancer agent. Current cancer drug targets 20030201
Induction of histone acetylation and inhibition of growth of mouse erythroleukemia cells by S-allylmercaptocysteine. Nutrition and cancer 20020101
Effect of garlic on cardiovascular disorders: a review. Nutrition journal 20020101
Therapeutic effect of S-allylmercaptocysteine on acetaminophen-induced liver injury in mice. European journal of pharmacology 20011221
Antiproliferative effects of S-allylmercaptocysteine on colon cancer cells when tested alone or in combination with sulindac sulfide. Cancer research 20010115
Properties